The predictors of progression of myocardial dysfunction in patients with nSTEMI within 6 months of follow-up

dc.contributor.author	Danilevych, T. D.
dc.contributor.author	Ivanov, V. P.
dc.contributor.author	Scherbak, O. V.
dc.contributor.author	Scherbak, V. P.
dc.date.accessioned	2025-03-23T18:24:45Z
dc.date.available	2025-03-23T18:24:45Z
dc.date.issued	2020
dc.identifier.citation	Danilevych T. D. The predictors of progression of myocardial dysfunction in patients with nSTEMI within 6 months of follow-up / T. D. Danilevych, V. P. Ivanov, O. V. Scherbak, V. P. Scherbak // European Journal of Heart Failure. – 2020. – №22 (Suppl. 1) – P2122	uk_UA
dc.identifier.issn	1388-9842
dc.identifier.uri	https://dspace.vnmu.edu.ua/123456789/8824
dc.description.abstract	We examined independent predictors of myocardial dysfunction (MD) progression in nSTEMI patients within 6 months of follow-up. Higher percent of fibrosis, presence of previous MI, and the size of left atrium were significant predictors of worsening MD.	uk_UA
dc.language.iso	en	uk_UA
dc.publisher	European Society of Cardiology	uk_UA
dc.subject	myocardial dysfunction	uk_UA
dc.subject	nSTEMI	uk_UA
dc.subject	echocardiography	uk_UA
dc.title	The predictors of progression of myocardial dysfunction in patients with nSTEMI within 6 months of follow-up	uk_UA
dc.type	Thesis	uk_UA